3D Signatures Inc.

DXD:TSX.V; TDSGF:OTCQB; 3D0:FSE

Last:
Change: Change(%):
Volume: Open:
High: Low:
52Wk High: 52Wk Low:

3D Signatures Inc. is a personalized medicine company with a proprietary software platform based on the three-dimensional analysis of a patient's individual chromosomal arrangement − or signature. The technology is well developed and supported by 16 clinical studies on over 1,500 patients on 13 different cancers and Alzheimer's disease. Depending on the application, the technology can measure the stage of disease, rate of progression of disease, drug efficacy, and drug toxicity. The technology is designed to predict the course of disease and to personalize treatment for the individual patient.